While we observed no changes in dual-phosphorylated ERK, we did observe an increase in phospho-AKT levels, a trend previously demonstrated to be associated with mislocalized EGFR and commonly found in cancers such as prostate, ovarian, and breast [18, 23, 24] (Supplementary Figure 3). The gene discussed is AKT1; the disease is cancer.